Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

TIMP-1 levels and their association with the development and progression of systemic malignancies.

Kapoor S.

Int J Biol Markers. 2013 Jun 28;28(2):231. doi: 10.5301/jbm.5000002. No abstract available.

PMID:
23558938
2.

MMP-9 overexpression due to TIMP-1 and RECK underexpression is associated with prognosis in prostate cancer.

Reis ST, Pontes-Junior J, Antunes AA, de Sousa-Canavez JM, Dall'Oglio MF, Passerotti CC, Abe DK, Crippa A, da Cruz JA, Timoszczuk LM, Srougi M, Leite KR.

Int J Biol Markers. 2011 Oct-Dec;26(4):255-61. doi: 10.5301/JBM.2011.8831.

PMID:
22139647
4.

Expression of matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) genes in blasts of infant acute lymphoblastic leukemia with organ involvement.

Suminoe A, Matsuzaki A, Hattori H, Koga Y, Ishii E, Hara T.

Leuk Res. 2007 Oct;31(10):1437-40. Epub 2007 Mar 9.

PMID:
17350093
7.

Effect of all-trans retinoic acid on renal expressions of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rats with glomerulosclerosis.

Qin YH, Lei FY, Hu P, Pei J, Feng ZB, Pang YS.

Pediatr Nephrol. 2009 Aug;24(8):1477-86. doi: 10.1007/s00467-009-1166-1. Epub 2009 Apr 9.

PMID:
19357873
8.

Remodeling associated expression of matrix metalloproteinase 9 but not tissue inhibitor of metalloproteinase 1 in airway epithelium: modulation by immunostimulatory DNA.

Cho JY, Miller M, McElwain K, McElwain S, Shim JY, Raz E, Broide DH.

J Allergy Clin Immunol. 2006 Mar;117(3):618-25.

PMID:
16522462
9.
10.

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer.

Suzuki M, Iizasa T, Fujisawa T, Baba M, Yamaguchi Y, Kimura H, Suzuki H.

Invasion Metastasis. 1998-1999;18(3):134-41.

PMID:
10474026
11.
12.

[Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].

Hu XX, Li L, Li DR, Zhang W, Cheng XQ, Zhang JQ, Tang BJ.

Ai Zheng. 2004 Oct;23(10):1194-8. Chinese.

PMID:
15473934
14.
15.

Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization.

Ma DH, Chen JK, Kim WS, Hao YX, Wu HC, Tsai RJ, Hwang DG, Zhang F.

Ophthalmic Res. 2001 Nov-Dec;33(6):353-62.

PMID:
11721189
17.

Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.

Russell RE, Culpitt SV, DeMatos C, Donnelly L, Smith M, Wiggins J, Barnes PJ.

Am J Respir Cell Mol Biol. 2002 May;26(5):602-9.

PMID:
11970913
18.

Gelatinase and inhibitor expression in soft tissue sarcomas: lack of correlation with distant metastasis.

Maguire PD, Qi W, Lallemand R, Scully SP.

Oncology. 2000 Aug;59(2):139-44.

PMID:
10971173
20.

Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.

Chen CL, Huang SK, Lin JL, Lai LP, Lai SC, Liu CW, Chen WC, Wen CH, Lin CS.

J Mol Cell Cardiol. 2008 Dec;45(6):742-53. doi: 10.1016/j.yjmcc.2008.07.007. Epub 2008 Jul 23.

PMID:
18692064

Supplemental Content

Support Center